Cutting-Edge Basic Research Awards (CEBRA) (R21)
Funding Amount:$250,000 total for 2 years |
Sponsor Deadline:Aug. 20, 2012
|
Letter of Intent Deadline:
|
Program Website:http://grants.nih.gov/grants/guide/pa-files/PAR-12- 086.html
|
The National Institute on Drug Abuse (NIDA) invites applications for Cutting-Edge Basic Research Awards (CEBRA) to foster highly innovative or conceptually creative research that advances our understanding of drug abuse and addiction and how to prevent and treat them. The CEBRA mechanism was designed by NIDA to foster novel research approaches and represents the high priority placed by NIDA on identifying such research. NIDA currently supports a great deal of innovative biomedical research on drug addiction and related health problems such as pain, HIV/AIDS, and obesity. The CEBRA, however, is specifically designed to support research that is high-risk and potentially high-impact and that is underrepresented or not included in NIDA's current portfolio. It is not intended for incremental research or research extending ongoing programs. It is aimed at both:
- drug abuse research investigators who wish to develop or adapt new methods or techniques, or to test novel hypotheses; and
- investigators with expertise in fields other than drug abuse who wish to establish innovative programs in drug abuse or develop new approaches or technologies that will advance drug abuse and related research.
The CEBRA R21 program is not intended for large-scale undertakings or to support or supplement ongoing research. The research proposed in a CEBRA application should break new ground or extend previous discoveries toward new directions or applications. For the CEBRA program, “basic research” is broadly inclusive. CEBRA applications will be considered for all Divisions of NIDA.
The goal of NIDA's CEBRA program is to accelerate the pace of discoveries that can advance addiction research by encouraging scientifically sound applications that focus on innovation. The CEBRA seeks to encourage researchers to explore new approaches, test imaginative new ideas, and challenge existing paradigms in drug addiction research in both humans and animal models. The CEBRA program will support high-risk, high impact research that either:
- tests a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; or
- develops or adapts innovative techniques or methods for addiction research, or of potential future use in addiction research.
There is enormous potential for advances when knowledge is generated and combined in new and unexpected ways. Therefore, this announcement encourages applications from investigators with experience in drug abuse research who wish to explore new methods, techniques or conceptual frameworks to study basic questions in drug abuse and addiction. It also encourages applications from investigators with expertise in fields other than drug abuse who wish to establish innovative research programs in drug abuse and addiction or to develop new approaches, techniques or technologies that have the potential for high-impact applications in drug abuse research.
